Navigation Links
Derma Sciences Announces Agreement With MedAssets for MEDIHONEY(TM) Wound & Burn Dressings
Date:4/23/2008

nicians with additional options to help heal patients. MEDIHONEY appears to offer incremental clinical benefits that may better enable our customers to provide optimal wound care."

Speaking of the new agreement, Derma Sciences' CEO Ed Quilty stated, "This is an important milestone for us. Group purchasing agreements such as this one will open up vast new selling opportunities for our growing sales team. MedAssets is a prominent group purchasing organization and we are pleased they decided to enter into an agreement with Derma for our proprietary product. We look forward to educating their customers on the benefits of MEDIHONEY."

About Derma Sciences

Derma Sciences is a global manufacturer and marketer of advanced wound- care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey- based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of two positive large-scale randomized controlled studies on leg ulcers. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.

About MedAssets

MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, 2,500 hospitals and 30,000 non- acute ca
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Galderma Completes Acquisition of CollaGenex
2. AGI Dermatics Closes $5 Million Investment Round
3. EnzySurge, Maker of DermaStream(TM), Establishes a US Office in the Virginia Biotech Commercialization Center
4. Derma Sciences Reports Fourth Quarter Year-End Results for 2007
5. Derma Sciences MEDIHONEY(TM) Profiled in Several Television News Health Reports
6. Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA
7. Biologics, Derma Fillers are Key to Dermatological Drug Market Growth
8. Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology
9. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
10. JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
11. Lucid Launches VivaNet(R) Telemedicine Server for Dermatology Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 3, 2015 E-QURE Corp. (OTCQB: ... its Bio-electrical Signal Therapy device ("BST Device"), a new ... to heal chronic wounds, today announced that the Company ... Israeli distributor specializing in medical devices, for the marketing ... is a 70 years old, sales, marketing and distribution ...
(Date:7/31/2015)... , July 31, 2015 In ... resources that help them drive positive health outcomes, ... vital source of patient care in their communities. ... annual tradeshow and conference, AmerisourceBergen announced a new ... Pharmacy Services Administration Organization and help independent pharmacies ...
(Date:7/30/2015)... 30, 2015 AACC welcomed thousands of ... AACC Annual Meeting & Clinical Lab Expo in ... The meeting showcased revolutionary advancements in clinical testing ... healthcare providers to diagnose patients quickly and accurately ... As of Wednesday, July 29, ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... of a field clinical study of its canine osteoarthritis stem cell product, currently ... Therapeutics (Kansas City, KS) and will be marketed in the US by Aratana. ...
Breaking Biology Technology:E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 2AmerisourceBergen Unveils Suite of Enhanced Capabilities for Independent Pharmacies at ThoughtSpot 2015 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 2Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 3Innovative Research on Cancer, Heart Disease, and Infectious Diseases Draws More than 17,500 Attendees to 2015 AACC Annual Meeting 4VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3
... Transposagen Biopharmaceuticals, Inc . ... genetic modification technology, have announced a non-exclusive marketing and distribution ... ™ technology. The piggyBac ... Modification System enables researchers to: Alter the ...
... CARLSBAD, Calif., May 11, 2011 Life Technologies Corporation ... that over 3,800 of its employees worldwide are scheduled to ... benefit their communities as part of the company,s eighth annual ... than 15,000 hours of community service at 48 sites in ...
... Technologies, Inc. today announced that positive preclinical data ... Paris, France on May 18, 2011 in a ... DES with a Fully-absorbable Coating and Enhanced Drug ... ("MiStent DES") is an ultra-thin, advanced alloy drug-eluting ...
Cached Biology Technology:Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 2Transposagen's piggyBac™ Vectors to be Distributed by System Biosciences 3Life Technologies Employees 'Give Back' to Their Communities During Eighth Annual Global Volunteer Day 2Life Technologies Employees 'Give Back' to Their Communities During Eighth Annual Global Volunteer Day 3Life Technologies Employees 'Give Back' to Their Communities During Eighth Annual Global Volunteer Day 4Life Technologies Employees 'Give Back' to Their Communities During Eighth Annual Global Volunteer Day 5Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR 2Micell Technologies Reports Preclinical Data for MiStent™ Drug-Eluting Coronary Stent to be Presented at EuroPCR 3
(Date:7/31/2015)... , 31 de julho de 2015 A ... www.icg-10.org ) será realizada pela BGI de 22-25 de outubro ... A conferência está celebrando seu 10 o. ... a ICG se tornou uma das reuniões mais influentes ... encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/27/2015)...   Zynx Health ™, the market leader ... today announced that its ZynxCarebook ™ mobile ... smartphones and tablets. With this expansion, care team ... ZynxCarebook to securely exchange messages and share assessments ... to other care settings, and improve clinical outcomes ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... nine out of 10 new cancer drugs successfully ... in human clinical testing. A new partnership facilitated ... outcome. The partnership brings together The UC ... National Cancer Institute,s (NCI) Center for Advanced Preclinical ...
... image shows the huge plume of sulphur dioxide that spewed ... Andes about 600 km south of Santiago. After lying ... earthquakes signalled the beginnings of this major volcanic eruption. On ... volcanic ash and gas over 10 km high. ,Several thousand ...
... Bethesda, MD The Federation of American Societies ... its newest client, the International Conference on Human Immunity ... Emory Conference Center in Atlanta, Georgia, on April 13-14, ... provide meeting management services. One of the organizers, ...
Cached Biology News:NCI partners with Jackson Laboratory, UC Davis to speed cancer clinical trials 2NCI partners with Jackson Laboratory, UC Davis to speed cancer clinical trials 3
Goat polyclonal to Sarcosine Oxidase ( Abpromise for all tested applications). Antigen: Microbial Sarcosine Oxidase. Entrez Gene ID: 51268 Swiss Protein ID: Q6IAJ9...
Rabbit polyclonal to TAB1 ( Abpromise for all tested applications). entrezGeneID: 10454 SwissProtID: Q15750...
Rabbit polyclonal to XPC ( Abpromise for all tested applications). Antigen: Synthetic peptide from N-terminus of Human XPC conjugated to a carrier protein Entrez Gene ID: 7508 Swiss ...
Chicken polyclonal to HADHSC - Azide free ( Abpromise for all tested applications). Antigen: Amino acids 57-314 of HADHSC Entrez GeneID: 3033 Swiss Protein ID: Q16836...
Biology Products: